ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 85 filers reported holding ALLOVIR INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,535,712 | -19.2% | 1,179,241 | +27.7% | 0.00% | – |
| Q2 2023 | $3,139,597 | +0.8% | 923,411 | +16.8% | 0.00% | – |
| Q1 2023 | $3,115,247 | +79594.2% | 790,672 | +3.8% | 0.00% | -100.0% |
| Q4 2022 | $3,909 | -99.9% | 762,003 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $5,955,000 | +177.1% | 754,766 | +37.0% | 0.00% | – |
| Q2 2022 | $2,149,000 | -42.1% | 551,055 | +0.2% | 0.00% | – |
| Q1 2022 | $3,712,000 | -46.7% | 550,031 | +2.2% | 0.00% | -100.0% |
| Q4 2021 | $6,963,000 | -46.0% | 538,153 | +4.7% | 0.00% | -50.0% |
| Q3 2021 | $12,884,000 | +51.2% | 514,163 | +19.1% | 0.00% | +100.0% |
| Q2 2021 | $8,519,000 | -14.9% | 431,583 | +0.9% | 0.00% | -50.0% |
| Q1 2021 | $10,005,000 | -16.0% | 427,584 | +38.0% | 0.00% | 0.0% |
| Q4 2020 | $11,911,000 | +44.9% | 309,873 | +3.7% | 0.00% | 0.0% |
| Q3 2020 | $8,220,000 | – | 298,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |